Skip to main content
Year archive

Transgene — 2010 filings

All 34 regulatory filings released by Transgene (TNG) in 2010, sourced directly from the official regulator.

34 Filings
2010 Period
2010 filings (34)
Filing Released Lang
Transgene : Rapport financier trimestriel au 30 septembre 2010
Interim / Quarterly Report 9M 2010
2010-10-18 French
Transgene: Third Quarter 2010 Financial report
Interim / Quarterly Report 9M 2010
2010-10-18 English
Transgene signe un accord avec Ventana Medical Systems, Inc. pour le développement d'un test de diagnostic associé pour le produit TG4010 de Transgene
Regulatory Filings
2010-09-29 French
TRANSGENE : Transgene signs an agreement with Ventana Medical Systems, Inc. to develop a companion diagnostic test for Transgene's TG4010
Regulatory Filings
2010-09-29 English
Transgene : communiqué de mise à disposition du rapport financier semestriel au 30 juin 2010
Report Publication Announcement H1 2010
2010-09-27 French
TRANSGENE : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2010
Interim / Quarterly Report H1 2010
2010-09-27 French
TRANSGENE : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2010
Interim / Quarterly Report H1 2010
2010-09-27 French
Transgene et Jennerex concluent un partenariat exclusif pour le développement et la commercialisation de JX-594 pour le traitement de cancers
Capital/Financing Update
2010-09-08 French
Jennerex and Transgene Enter into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Regulatory Filings
2010-09-08 English
Transgene : résultats du premier semestre 2010 conformes aux attentes
Interim / Quarterly Report H1 2010
2010-09-01 French
Transgene Reports First Half 2010 Results In Line with Expectations
Interim / Quarterly Report H1 2010
2010-09-01 English
Transgene Receives Positive Scientific Advice from the European Medicines Agency for the Phase IIb/III trial of its Targeted Immunotherapy Product TG4010 for the Treatment of Non-Small Cell Lung Cance
Regulatory Filings
2010-09-01 English
Transgene obtient un avis scientifique positif de l'Agence Européenne des Médicaments (EMA) sur l'étude de phase IIb/III de son produit d'immunothérapie ciblée TG4010 pour le traitement du cancer du p
Regulatory Filings
2010-09-01 French
Transgene announces opening of First clinical site for its Phase II trial of TG4040 for the treatment of chronic hepatitis C
Legal Proceedings Report
2010-07-12 English
Transgene : ouverture du premier centre clinique pour la phase II de TG4040 contre l'hépatite C chronique
Regulatory Filings Q3 2010
2010-07-12 French
TRANSGENE ANNONCE DES MODIFICATIONS AU SEIN DE SON CONSEIL D'ADMINISTRATION
Board/Management Information
2010-06-17 French
Transgene announces changes to its Board of Directors
Board/Management Information
2010-06-17 English
Transgene announces successful rights issue
Share Issue/Capital Change
2010-06-03 English
TRANSGENE annonce le succès de son augmentation de capital
Share Issue/Capital Change
2010-06-03 French
TRANSGENE : Rapport financier trimestriel - Période du 1er janvier au 31 mars 2010
Interim / Quarterly Report Q1 2010
2010-05-11 French
TRANSGENE : Rapport financier trimestriel - Période du 1er janvier au 31 mars 2010
Interim / Quarterly Report Q1 2010
2010-05-11 French
Transgene annonce le lancement d'une augmentation de capital avec maintien du droit préférentiel de souscription
Capital/Financing Update
2010-05-10 French
Transgene announces the launch of a capital increase with preferential subscription rights
Share Issue/Capital Change
2010-05-10 English
TRANSGENE: Cash position of E55.7m as of 31st March 2010
Earnings Release Q1 2010
2010-04-19 English
Transgene : trésorerie de 55,7 ME au 31 mars 2010
Earnings Release Q1 2010
2010-04-19 French
Transgene : communique de mise à disposition du document de référence 2009
Report Publication Announcement
2010-04-15 French
TRANSGENE ANNONCE UN PROJET D'AUGMENTATION DE SES FONDS PROPRES
Share Issue/Capital Change
2010-03-23 French
TRANSGENE ANNOUNCES ITS INTENT TO RAISE FUNDS
Capital/Financing Update
2010-03-23 English
TRANSGENE : Transgene : revue du portefeuille de produits, de l'activité et des perspectives stratégiques
Investor Presentation
2010-03-22 French
Transgene Reports Full Year 2009 Results
Earnings Release FY 2009
2010-03-22 English
Transgene : résultats annuels 2009
Earnings Release FY 2009
2010-03-22 French
Transgene Reviews Product Pipeline, Provides a Business Update and Outlines its Corporate Strategy
Investor Presentation
2010-03-22 English
Transgene signs an exclusive option agreement for the development and commercialisation of its immunotherapy product TG4010
Capital/Financing Update
2010-03-10 English
Transgene accorde une option de licence exclusive pour le développement et la commercialisation de son produit d'immunothérapie TG4010
Regulatory Filings
2010-03-10 French